EUVIMEDEUVIMED entdecken
Crossref

Evaluation of fetal myocardial performance index in gestational diabetes mellitus

Merve Ozturk iD, Zahid Agaoglu, Filiz Halici Ozturk, Kadriye Yakut, Fatma Doğa Öcal, Yuksel Oguz, Turhan Caglar

Congenital Anomalies · 2023

DOI: 10.1111/cga.12531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Congenital Anomalies, 2023. Verfasst von Merve Ozturk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatology, Turkish Ministry of Health, Ankara City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Diabetes, Gestational, Insulins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to compare fetal myocardial performance index (MPI) between fetuses of pregnant women with gestational diabetes mellitus (GDM) and healthy controls and to evaluate the relationship between MPI and maternal glucose levels. This was a prospective study of 90 pregnant women, including 50 pregnancies with GDM (27 pregnancies with insulin‐regulated GDM and 23 pregnancies with diet‐regulated GDM) and 40 healthy controls. Isovolumetric contraction time (ICT) + isovolumetric relaxation time (IRT)/ejection time (ET) were used to calculate the MPI (MPI = [ICT + IRT]/ET). Fetal MPI, PR interval, E/A ratio, maternal plasma glucose levels on the day of MPI measurement, and neonatal outcomes were compared. The fetal left‐MPI was significantly higher in the GDM group than healthy controls (0.43 ± 0.04 vs. 0.40 ± 0.06, p = 0.007). The best cut‐off level for MPI was >0.41 to predict adverse perinatal outcomes (sensitivity: 70%, specificity: 68%, area under the curve: 0.715, 95% confidence interval: 0.5143–0.8205, p < 0.001). The fetal MPI values showed no correlation with maternal plasma fasting, postprandial glucose, and hemoglobin A1c (HbA1c) levels. Reduced E/A ratio, higher neonatal intensive care unit admissions, and the need for cesarean delivery were detected in the GDM group. Fetal MPI is impaired in women with GDM, and the need for insulin therapy is associated with higher MPI values and adverse neonatal outcomes. Fetal MPI can help detect fetuses with potential adverse outcome risks, owing to impaired fetal cardiac function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalInsulinsInfant, NewbornPregnancyFemaleHumansProspective StudiesFetal HeartEchocardiography, DopplerGlucose

Stichwörter der Autor:innen

diabetesfetal heartmyocardial performance indexpregnancy

Substanzen

GlucoseInsulins

Autor:innen und Institutionen

  • Department of Perinatology, Turkish Ministry of Health, Ankara City Hospital, Ankara, Turkey.
  • Department of Perinatology, Etlik Zubeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.

ORCID-Profile: Merve Ozturk

Zitieren

APA

Ozturk, M., Agaoglu, Z., Ozturk, F. H., Yakut, K., Öcal, F. D., Oguz, Y., & Caglar, T. (2023). Evaluation of fetal myocardial performance index in gestational diabetes mellitus. Congenital Anomalies. https://doi.org/10.1111/cga.12531

Vancouver

Ozturk M, Agaoglu Z, Ozturk FH, Yakut K, Öcal FD, Oguz Y, et al. Evaluation of fetal myocardial performance index in gestational diabetes mellitus. Congenital Anomalies. 2023. doi:10.1111/cga.12531

BibTeX
@article{Ozturk2023,
  author = {Ozturk, Merve and Agaoglu, Zahid and Ozturk, Filiz Halici and Yakut, Kadriye and Öcal, Fatma Doğa and Oguz, Yuksel and Caglar, Turhan},
  title = {Evaluation of fetal myocardial performance index in gestational diabetes mellitus},
  journal = {Congenital Anomalies},
  year = {2023},
  doi = {10.1111/cga.12531}
}
Kostenlos starten →